Literature DB >> 17927462

Reasons provided by prescribers when overriding drug-drug interaction alerts.

Amy J Grizzle1, Maysaa H Mahmood, Yu Ko, John E Murphy, Edward P Armstrong, Grant H Skrepnek, William N Jones, Gregory P Schepers, W Paul Nichol, Antoun Houranieh, Donna C Dare, Christopher T Hoey, Daniel C Malone.   

Abstract

OBJECTIVES: To investigate prescribers' rationales for overriding drug-drug interaction (DDI) alerts and to determine whether these reasons were helpful to pharmacists as a part of prescription order verification. STUDY
DESIGN: An observational retrospective database analysis was conducted using override reasons derived from a computerized system at 6 Veterans Affairs medical centers.
METHODS: Data on DDI alerts (for interactions designated as "critical" and "significant") were obtained from ambulatory care pharmacy records from July 1, 2003, to June 30, 2004. Prescribers' reasons for overriding alerts were organized into 14 categories and were then rated as clinically useful or not to the pharmacist in the assessment of potential patient harm.
RESULTS: Of 291,890 overrides identified, 72% were for critical DDIs. Across the Veterans Affairs medical centers, only 20% of the override reasons for critical DDI alerts were rated as clinically useful for order verification. Despite a mandatory override reason for critical DDI alerts, 53% of the responses were "no reason provided." The top response categories for critical and significant DDI alerts were "no reason provided," "patient has been taking combination," and "patient being monitored."
CONCLUSIONS: When given the opportunity to provide a reason for overriding a DDI alert, prescribers rarely enter clinical justifications that are useful to order verification pharmacists. This brings into question how computerized physician order entry systems should be designed.

Entities:  

Mesh:

Year:  2007        PMID: 17927462

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  34 in total

Review 1.  Computer-assisted versus oral-and-written dietary history taking for diabetes mellitus.

Authors:  Igor Wei; Yannis Pappas; Josip Car; Aziz Sheikh; Azeem Majeed
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  The role of informatics in health care reform.

Authors:  Yueyi I Liu; Daniel L Rubin
Journal:  Acad Radiol       Date:  2012-07-06       Impact factor: 3.173

3.  Randomized clinical trial of a customized electronic alert requiring an affirmative response compared to a control group receiving a commercial passive CPOE alert: NSAID--warfarin co-prescribing as a test case.

Authors:  Brian L Strom; Rita Schinnar; Warren Bilker; Sean Hennessy; Charles E Leonard; Eric Pifer
Journal:  J Am Med Inform Assoc       Date:  2010 Jul-Aug       Impact factor: 4.497

4.  Medical alert management: a real-time adaptive decision support tool to reduce alert fatigue.

Authors:  Eva K Lee; Tsung-Lin Wu; Tal Senior; James Jose
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14

5.  SFINX-a drug-drug interaction database designed for clinical decision support systems.

Authors:  Ylva Böttiger; Kari Laine; Marine L Andersson; Tuomas Korhonen; Björn Molin; Marie-Louise Ovesjö; Tuire Tirkkonen; Anders Rane; Lars L Gustafsson; Birgit Eiermann
Journal:  Eur J Clin Pharmacol       Date:  2009-02-11       Impact factor: 2.953

6.  Alert override reasons: a failure to communicate.

Authors:  Amy E Chused; Gilad J Kuperman; Peter D Stetson
Journal:  AMIA Annu Symp Proc       Date:  2008-11-06

7.  A human factors investigation of medication alerts: barriers to prescriber decision-making and clinical workflow.

Authors:  Alissa L Russ; Alan J Zillich; M Sue McManus; Bradley N Doebbeling; Jason J Saleem
Journal:  AMIA Annu Symp Proc       Date:  2009-11-14

8.  Development and validation of a survey instrument for assessing prescribers' perception of computerized drug-drug interaction alerts.

Authors:  Kai Zheng; Kathleen Fear; Bruce W Chaffee; Christopher R Zimmerman; Edward M Karls; Justin D Gatwood; James G Stevenson; Mark D Pearlman
Journal:  J Am Med Inform Assoc       Date:  2011-04-12       Impact factor: 4.497

9.  Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital.

Authors:  L Gschwind; V Rollason; C Lovis; F Boehlen; P Bonnabry; P Dayer; J A Desmeules
Journal:  Eur J Clin Pharmacol       Date:  2012-08-19       Impact factor: 2.953

Review 10.  Clinical decision support alert appropriateness: a review and proposal for improvement.

Authors:  Allison B McCoy; Eric J Thomas; Marie Krousel-Wood; Dean F Sittig
Journal:  Ochsner J       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.